| Descriptor English: | Proto-Oncogene Proteins c-mos | ||||||
| Descriptor Spanish: |
Proteínas Proto-Oncogénicas c-mos
| ||||||
| Descriptor Portuguese: | Proteínas Proto-Oncogênicas c-mos | ||||||
| Descriptor French: | Protéines proto-oncogènes c-mos | ||||||
| Entry term(s): |
Cytostatic Factor Products c-mos, Proto-Oncogene Proteins c-mos, Proto-Oncogene Proteins mos, Proto-Oncogene Proteins, c-mos Proteins, mos Proto-Oncogene Proto Oncogene Products c mos Proto Oncogene Proteins c mos Proto Oncogene Proteins mos Proto-Oncogene Products c-mos Proto-Oncogene Proteins mos Proto-Oncogene Proteins, mos c mos Proteins c-mos Proteins c-mos, Proto-Oncogene Products c-mos, Proto-Oncogene Proteins c-mos, pp39 mos Proto Oncogene Product pp39 mos Proto Oncogene Proteins mos Proto-Oncogene Product pp39 mos Proto-Oncogene Proteins pp39 c mos pp39 c-mos pp39(c-mos) |
||||||
| Tree number(s): |
D08.811.913.696.620.682.700.559.800 D12.776.476.563.554.800 D12.776.624.664.700.187 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D017231 | ||||||
| Scope note: | Cellular proteins encoded by the c-mos genes (GENES, MOS). They function in the cell cycle to maintain MATURATION PROMOTING FACTOR in the active state and have protein-serine/threonine kinase activity. Oncogenic transformation can take place when c-mos proteins are expressed at the wrong time. |
||||||
| Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
| Registry Number: | EC 2.7.11.1 | ||||||
| Previous Indexing: |
Proto-Oncogene Proteins (1987-1992) |
||||||
| Public MeSH Note: | 93; PROTO-ONCOGENE PROTEIN C-MOS (NM) was indexed under PROTO-ONCOGENE PROTEINS 1987-92 |
||||||
| Online Note: | use PROTO-ONCOGENE PROTEINS C-MOS (NM) to search PROTO-ONCOGENE PROTEIN C-MOS 1987-92 |
||||||
| History Note: | 93; was PROTO-ONCOGENE PROTEIN C-MOS (NM) 1987-92 |
||||||
| DeCS ID: | 30588 | ||||||
| Unique ID: | D017231 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 1993/01/01 | ||||||
| Date of Entry: | 1992/05/22 | ||||||
| Revision Date: | 2015/11/24 |
-
-
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
|
Proto-Oncogene Proteins c-mos
- Preferred
| Concept UI |
M0026143 |
| Scope note | Cellular proteins encoded by the c-mos genes (GENES, MOS). They function in the cell cycle to maintain MATURATION PROMOTING FACTOR in the active state and have protein-serine/threonine kinase activity. Oncogenic transformation can take place when c-mos proteins are expressed at the wrong time. |
| Preferred term | Proto-Oncogene Proteins c-mos |
| Entry term(s) |
Cytostatic Factor Products c-mos, Proto-Oncogene Proteins c-mos, Proto-Oncogene Proteins mos, Proto-Oncogene Proteins, c-mos Proteins, mos Proto-Oncogene Proto Oncogene Products c mos Proto Oncogene Proteins c mos Proto Oncogene Proteins mos Proto-Oncogene Products c-mos Proto-Oncogene Proteins mos Proto-Oncogene Proteins, mos c mos Proteins c-mos Proteins c-mos, Proto-Oncogene Products c-mos, Proto-Oncogene Proteins c-mos, pp39 mos Proto Oncogene Product pp39 mos Proto Oncogene Proteins mos Proto-Oncogene Product pp39 mos Proto-Oncogene Proteins pp39 c mos pp39 c-mos pp39(c-mos) |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
